Mechanisms of Antibiotic Resistance in Bacteria

A special issue of Pathogens (ISSN 2076-0817). This special issue belongs to the section "Bacterial Pathogens".

Deadline for manuscript submissions: closed (30 April 2023) | Viewed by 4372

Special Issue Editors


E-Mail
Guest Editor
Área de Microbiología, Departamento de Farmacia, Instituto de Ciencias Biomédicas, Facultad de Ciencias de la Salud, Universidad Cardenal Herrera—CEU, CEU Universities, Alfara del Patriarca, 46115 Valencia, Spain
Interests: antibiotic resistance; multidrug-resistant bacteria; clinical microbiology; clinical virology
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Departamento de Producción y Sanidad Animal, Salud Pública Veterinaria y Ciencia y Tecnología de los Alimentos, Instituto de Ciencias Biomédicas, Facultad de Veterinaria, Universidad Cardenal Herrera-CEU, CEU Universities, Avenida Seminario s/n, 46113 Moncada, Spain
Interests: microbiology; multidrug resistances; zoonotic pathogens; epidemiology
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Departamento de Matemáticas, Física y Ciencias Tecnológicas, Universidad Cardenal Herrera-CEU, CEU Universities, San Bartolomé 55, 46115 Alfara del Patriarca (Valencia), Spain
Interests: antibiotic resistance; drug development; drug repurposing

Special Issue Information

Dear Colleagues, 

Antibiotic resistance (AR) developed by bacteria is considered by the World Health Organization (WHO) as one of the main threats to global health.  The alarming increase in this resistance is undoubtedly one of the greatest current public health problems since these compounds constitute one of the main tools for controlling and treating bacterial infections both in human and veterinary medicine. The problem is multisectoral and involves many complex challenges. In addition to medical components, it has economic, ecological, sociological and developmental dimensions. In the 21st century, infectious diseases remain one of the most important causes of death in humanity, although their relative contribution has been decreasing since the 19th century.  The introduction of antibiotics into clinical practice during the 1940s was one of the most important interventions for their control and increased the life expectancy of the population by several years. Antibiotics have saved millions of lives, but they have also brought about a revolution in medicine. They have contributed significantly to progress in fields such as solid organ and hematopoietic progenitor transplants; survival of premature and immunocompromised patients (natural or by pharmacological therapies); prosthetic surgery; and vascular catheters, where infections are particularly prevalent and important. Currently, antibiotics are the most prescribed and consumed drugs in the world.  The loss of efficacy of these drugs is leading to a silent tsunami that is silently invading the world and collapsing the pillars on which modern medicine is based upon. Antibiotic resistance is not only a future threat; it is present here and now. For these reasons, this situation requires immediate action, and we must all share the responsibility of preserving antibiotics for current and future generations. This Special Issue welcomes all forms of articles, e.g., reviews, short reports, hypotheses, research articles, opinions and comments on mechanisms of antibiotic resistance in bacteria.

Prof. Dr. María-Teresa Pérez-Gracia
Prof. Dr. Clara Marín Orenga
Dr. Beatriz Suay-García
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • antibiotic resistance
  • mechanisms
  • superbugs
  • bacteria

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

24 pages, 917 KiB  
Review
ESKAPE and Beyond: The Burden of Coinfections in the COVID-19 Pandemic
by Miguel Ángel Loyola-Cruz, Luis Uriel Gonzalez-Avila, Arturo Martínez-Trejo, Andres Saldaña-Padilla, Cecilia Hernández-Cortez, Juan Manuel Bello-López and Graciela Castro-Escarpulli
Pathogens 2023, 12(5), 743; https://doi.org/10.3390/pathogens12050743 - 22 May 2023
Cited by 13 | Viewed by 3754
Abstract
The ESKAPE group constitute a threat to public health, since these microorganisms are associated with severe infections in hospitals and have a direct relationship with high mortality rates. The presence of these bacteria in hospitals had a direct impact on the incidence of [...] Read more.
The ESKAPE group constitute a threat to public health, since these microorganisms are associated with severe infections in hospitals and have a direct relationship with high mortality rates. The presence of these bacteria in hospitals had a direct impact on the incidence of healthcare-associated coinfections in the SARS-CoV-2 pandemic. In recent years, these pathogens have shown resistance to multiple antibiotic families. The presence of high-risk clones within this group of bacteria contributes to the spread of resistance mechanisms worldwide. In the pandemic, these pathogens were implicated in coinfections in severely ill COVID-19 patients. The aim of this review is to describe the main microorganisms of the ESKAPE group involved in coinfections in COVID-19 patients, addressing mainly antimicrobial resistance mechanisms, epidemiology, and high-risk clones. Full article
(This article belongs to the Special Issue Mechanisms of Antibiotic Resistance in Bacteria)
Show Figures

Graphical abstract

Back to TopTop